Mangalam Drugs reports continued default on bank loans worth Rs 15.85 cr

Loan NpaCredit & Debt View source PDF Explain this filing

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.6%Reaction day

₹31.90

prior close

₹32.20

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.0%-0.4% vs market

Pharmaceuticals peers, median of 157sector+0.2%+0.4% vs sector

On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250 and 0.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

+0.8

15m

+0.8

30m

+1.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.6+1.0-0.4+0.2+0.4

Next day

+0.8+1.3-0.5+0.6+0.2

-0.6-0.2-0.4-0.3-0.3

-1.2-0.3-0.9-0.5-0.7

-2.4-0.2-2.2-0.1-2.2

-6.2-1.4-4.8-1.6-4.6

-6.9-1.0-5.9-0.6-6.3

15d

+0.3-6.3+6.6-4.3+4.6

-3.5-9.0+5.5-5.8+2.3

-6.3+3.5-9.8+1.5-7.8

-4.7+4.6-9.3+4.2-8.9

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mangalam Drugs and Organics has reported ongoing defaults on two cash credit accounts exceeding 30 days. Bank of Maharashtra overdue stands at Rs 9.79 crore and Bank of Baroda at Rs 6.06 crore, totaling about Rs 15.85 crore. Defaults began in October 2025. The company says it is arranging to pay the overdue amounts soon.

Likely market impact

Negative signal - sustained loan defaults raise solvency concerns and risk of NPA classification, potentially hurting stock price and lender confidence.